TERABEAM, INC. (TRBM) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 216 transactions totaling $12.7M, demonstrating a bearish sentiment with -$12.2M in net insider flow. The most recent transaction on Aug 16, 2007 involved a purchase of 7,000 shares valued at $12.7K.
No significant insider buying has been recorded for TRBM in the recent period.
No significant insider selling has been recorded for TRBM in the recent period.
Based on recent SEC filings, insider sentiment for TRBM is bearish with an Insider Alignment Score of 2/100 and a net flow of -$12.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at TERABEAM, INC. (TRBM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading TRBM stock, having executed 216 transactions in the past 90 days. The most active insider is Robert E. Fitzgerald (Executive), who has made 68 transactions totaling $2.1M.
Get notified when executives and directors at TRBM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 16, 2007 | J. Sereda Brian | Executive | Purchase | 7,000 | $1.82 | $12.7K | |
| Aug 7, 2007 | E. Fitzgerald Robert | Executive | Sale | 7,500 | $2.10 | $15.8K | |
| Jul 23, 2007 | E. Fitzgerald Robert | Executive | Sale | 10,000 | $2.10 | $21.0K | |
| Jul 23, 2007 | E. Fitzgerald Robert | Executive | Sale | 10,000 | $2.20 | $22.0K | |
| Jun 13, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 2,800 | $2.15 | $6.0K | |
| Jun 12, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 5,000 | $2.00 | $10.0K | |
| Jun 12, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 5,000 | $2.03 | $10.2K | |
| Jun 11, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 3,700 | $2.03 | $7.5K | |
| Jun 11, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 1,300 | $2.13 | $2.8K | |
| Jun 8, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 11,300 | $2.14 | $24.2K | |
| Jun 8, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 100 | $2.17 | $217 | |
| Jun 8, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 700 | $2.15 | $1.5K | |
| Jun 8, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 100 | $2.16 | $216 | |
| Jun 7, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 3,101 | $2.16 | $6.7K | |
| Jun 7, 2007 | Ii, Llc Concorde Equity | Executive | Sale | 600 | $2.14 | $1.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 196 | $12.5M | 98.3% |
Purchase(P) | 19 | $220.1K | 1.7% |
Gift(G) | 1 | $0 | 0.0% |
Insider selling pressure at TERABEAM, INC. has increased, with 13 insiders executing 216 transactions across all time. Total sales of $12.5M significantly outpace purchases of $220.1K, resulting in a net outflow of $12.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.